Anavex Life Sciences financial statements
애너벡스 라이프 사이언시스NASDAQ:AVXL · Nasdaq · Healthcare · sector #17$1.60-2.74%
2026-10-06 closeAnavex Life Sciences's published financial data is dated 2026-10-04. 2025 revenue was $0M. 2025 operating profit was −$51M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy